TPST
Tempest Therapeutics, Inc.
Phase 2
AI-extracted
TPST-2003
relapsed/refractory multiple myeloma (rrMM)
157d ago
Jan 31, 2026
SEC 8-K
verified 13h ago
Countdown card →